Skip to content

Efficacy and Safety of Electroacupuncture for Generalized Anxiety Disorder: A Multicenter Randomized Controlled Study

Efficacy and Safety of Electroacupuncture for Generalized Anxiety Disorder: A Multicenter Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000161
Enrollment
Unknown
Registered
2025-01-25
Start date
2025-02-17
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

generalized anxiety disorder

Interventions

Control group:Treatment as usual(TAU) + sham acupuncture(shallow needling next to the acupoint, electricity off)
Intervention group:Treatment as usual(TAU) + electroacupuncture(Acupoints: Baihui, Shenting, Neiguan, Hegu, Taichong, Sanyinjiao, Guanyuan, and Zusanli. Parameter: continuous wave, 100Hz, intensity ba

Sponsors

The second Xiangya hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Subjects were determined to meet the diagnostic criteria for Generalized Anxiety Disorder (GAD) as per the DSM-5 through the Structured Clinical Interview for DSM Disorders (SCID) with a Hamilton Anxiety Rating Scale (HAMA) score greater than 14 points 2. Age range: 18-60 years old; 3. Participants had not received any pharmacological treatment for at least 4 weeks prior to the trial commencement or had been on stable pharmacological treatment for over 4 weeks. 4. Participants should have an educational level of junior high school or above and possess the capability to sign an informed consent form as well as to complete self-rating scales and cognitive assessments. 5. Participants are required to sign an informed consent document.

Exclusion criteria

Exclusion criteria: 1.Diagnosed as organic mental disorders or other mental disorders in DSM-5 except for anxiety disorders. 2.Individuals with severe suicidal ideation or a history of suicide attempts. 3.Individuals who have used beta-blockers within the past month; those with irregular caffeine intake should discontinue caffeine and those who consume caffeine daily should reduce their intake by half. 4. individuals who have received other non-pharmacological treatments within the last six months such as acupuncture Electroconvulsive Therapy (ECT) Repetitive Transcranial Magnetic Stimulation (rTMS) or systematic psychotherapy for a total of more than 10 sessions 5.Individuals with a history of alcohol and substance dependence. 6.Individuals with a history of cranial trauma or coma. 7.Individuals with brain organic lesions severe somatic or chronic somatic diseases that are not well controlled (such as thyroid diseases hemophilia lupus erythematosus or rheumatoid arthritis and other immune system diseases lung liver kidney damag

Design outcomes

Primary

MeasureTime frame
HAMA score;

Secondary

MeasureTime frame
Questionnaire on Living and Dietary Habits;SCOPA-AUT score;PHQ-15 score;HAMD score;BSI score;TESS score;Height;Face image;GAD-7 score;11-item heart rate and respairation scale;Demographic data;Single-cell sequencing;Flow cytometry;PHQ-9 score;STAI score;Pulse condition;TCM syndrome differentiation;Weight;Medication Dosage Log;Tongue image;Autonomic nervous function;cognitive assessments;

Countries

China

Contacts

Public ContactJin Liu

The second Xiangya hospital of Central South University

liujin975@csu.edu.cn13123392823

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026